199 related articles for article (PubMed ID: 15242869)
1. Characterization of acute lymphoblastic leukemia progenitor cells.
Cox CV; Evely RS; Oakhill A; Pamphilon DH; Goulden NJ; Blair A
Blood; 2004 Nov; 104(9):2919-25. PubMed ID: 15242869
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia.
Cox CV; Martin HM; Kearns PR; Virgo P; Evely RS; Blair A
Blood; 2007 Jan; 109(2):674-82. PubMed ID: 17003368
[TBL] [Abstract][Full Text] [Related]
3. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
[TBL] [Abstract][Full Text] [Related]
4. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
Blair A; Sutherland HJ
Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
[TBL] [Abstract][Full Text] [Related]
5. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.
Blair A; Hogge DE; Sutherland HJ
Blood; 1998 Dec; 92(11):4325-35. PubMed ID: 9834239
[TBL] [Abstract][Full Text] [Related]
6. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
Lapidot T; Grunberger T; Vormoor J; Estrov Z; Kollet O; Bunin N; Zaizov R; Williams DE; Freedman MH
Blood; 1996 Oct; 88(7):2655-64. PubMed ID: 8839860
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD133 on leukemia-initiating cells in childhood ALL.
Cox CV; Diamanti P; Evely RS; Kearns PR; Blair A
Blood; 2009 Apr; 113(14):3287-96. PubMed ID: 19147788
[TBL] [Abstract][Full Text] [Related]
8. In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
le Viseur C; Hotfilder M; Bomken S; Wilson K; Röttgers S; Schrauder A; Rosemann A; Irving J; Stam RW; Shultz LD; Harbott J; Jürgens H; Schrappe M; Pieters R; Vormoor J
Cancer Cell; 2008 Jul; 14(1):47-58. PubMed ID: 18598943
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
10. [Flow cytometric characterization of maturation processes and primitive stem cell population in pre-B-cell ALL in childhood].
Baersch G; Baumann M; Meltzer J; Möllers T; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1996; 208(4):160-7. PubMed ID: 8926682
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
12. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand.
Renard N; Lafage-Pochitaloff M; Durand I; Duvert V; Coignet L; Banchereau J; Saeland S
Blood; 1996 Jun; 87(12):5162-70. PubMed ID: 8652829
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
15. [Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].
Li JL; Liu YR; Qin YZ; Chang Y; Fu JY; Wang H; Ruan GR; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):142-5. PubMed ID: 12744735
[TBL] [Abstract][Full Text] [Related]
16. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.
Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F
Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041
[TBL] [Abstract][Full Text] [Related]
18. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
Pilarski LM; Belch AR
Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
[TBL] [Abstract][Full Text] [Related]
19. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
[TBL] [Abstract][Full Text] [Related]
20. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.
Xu M; Bruno E; Chao J; Ni H; Lindgren V; Nunez R; Mahmud N; Finazzi G; Fruchtman SM; Popat U; Liu E; Prchal JT; Rondelli D; Barosi G; Hoffman R
Blood; 2005 Feb; 105(4):1699-705. PubMed ID: 15471948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
